Post-COVID-19 Condition Tied to Health Care Access Issues

WEDNESDAY, April 12, 2023 (HealthDay News) -- U.S. adults with post-COVID-19 condition (PCC) are more likely than other adults to have difficulty getting and paying for health care, according to a study published online April 10 in JAMA Network Open.
Michael Karpman, from the Urban Institute in Washington, D.C., and colleagues examined the association of PCC with access and affordability challenges among 9,484 surveyed U.S. adults (aged 18 to 64 years).
The researchers found that 36.4 percent of respondents reported ever being diagnosed with COVID-19, and among these respondents, 22.5 percent reported currently having PCC. After adjustment for differences in demographic, health, and geographic characteristics, adults with PCC were more likely than both adults with a COVID-19 diagnosis but no report of PCC and adults never diagnosed with COVID-19 to report unmet health care needs in the past 12 months because of challenges, including costs (27.0 percent versus 18.3 and 17.5 percent, respectively), difficulties finding clinicians accepting new patients (16.4 percent versus 10.1 and 10.7 percent, respectively), getting a timely appointment (22.0 percent versus 14.4 and 13.9 percent, respectively), and getting health plan care authorization (16.6 percent versus 10.8 and 10.3 percent, respectively).
"These findings suggest that policies aimed at improving access and affordability may focus on accelerating development of treatments and clinical guidelines, training clinicians, and addressing insurance-related administrative and cost barriers," the authors write.
Related Posts
Prohibir los cigarrillos electrónicos con sabores puede lograr que los adolescentes dejen de vapear
VIERNES, 5 de mayo de 2023 (HealthDay News) -- Aunque las autoridades de salud...
COVID Boosters Raise Antibody Levels by 85% in Nursing Home Residents
MONDAY, June 27, 2022 (HealthDay News) -- Getting a COVID-19 booster shot can...
U.S. Life Expectancy Dropped Between 2019 and 2020
WEDNESDAY, April 13, 2022 (HealthDay News) -- U.S. life expectancy decreased...
FDA Approves Izervay for Geographic Atrophy Tied to Age-Related Macular Degeneration
WEDNESDAY, Aug. 9, 2023 (HealthDay News) -- The U.S. Food and Drug...
